WO2001064840A8 - Novel bone marrow nucleic acids and polypeptides - Google Patents

Novel bone marrow nucleic acids and polypeptides

Info

Publication number
WO2001064840A8
WO2001064840A8 PCT/US2001/006509 US0106509W WO0164840A8 WO 2001064840 A8 WO2001064840 A8 WO 2001064840A8 US 0106509 W US0106509 W US 0106509W WO 0164840 A8 WO0164840 A8 WO 0164840A8
Authority
WO
WIPO (PCT)
Prior art keywords
bone marrow
nucleic acids
polypeptides
novel bone
marrow nucleic
Prior art date
Application number
PCT/US2001/006509
Other languages
French (fr)
Other versions
WO2001064840A2 (en
Inventor
John E Ford
Bryan J Boyle
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Original Assignee
Hyseq Inc
John E Ford
Bryan J Boyle
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, John E Ford, Bryan J Boyle, Y Tom Tang, Chenghua Liu, Radoje T Drmanac filed Critical Hyseq Inc
Priority to AU2001241873A priority Critical patent/AU2001241873A1/en
Publication of WO2001064840A2 publication Critical patent/WO2001064840A2/en
Publication of WO2001064840A8 publication Critical patent/WO2001064840A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention porte sur de nouveaux acides nucléiques exprimés par la moelle osseuse, sur de nouvelles séquences de polypeptides codées par lesdits acides, et sur leurs utilisations.The invention relates to new nucleic acids expressed by bone marrow, to new sequences of polypeptides encoded by said acids, and to their uses.

PCT/US2001/006509 2000-02-28 2001-02-28 Novel bone marrow nucleic acids and polypeptides WO2001064840A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001241873A AU2001241873A1 (en) 2000-02-28 2001-02-28 Novel bone marrow nucleic acids and polypeptides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US51512600A 2000-02-28 2000-02-28
US09/515,126 2000-02-28
US57740900A 2000-05-18 2000-05-18
US09/577,409 2000-05-18
US25058300P 2000-11-30 2000-11-30
US60/250,583 2000-11-30

Publications (2)

Publication Number Publication Date
WO2001064840A2 WO2001064840A2 (en) 2001-09-07
WO2001064840A8 true WO2001064840A8 (en) 2002-03-21

Family

ID=27400340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/006509 WO2001064840A2 (en) 2000-02-28 2001-02-28 Novel bone marrow nucleic acids and polypeptides

Country Status (2)

Country Link
AU (1) AU2001241873A1 (en)
WO (1) WO2001064840A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2396352B (en) * 2000-02-04 2004-08-25 Aeomica Inc Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
WO2003006990A1 (en) * 2001-07-12 2003-01-23 Exelixis, Inc. Modifiers of the p21 pathway and methods of use

Also Published As

Publication number Publication date
WO2001064840A2 (en) 2001-09-07
AU2001241873A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
ATE469911T1 (en) ISOLATED NUCLEIC ACID MOLECULES ENCODING T-CELL INDUCIBLE FACTORS (TIF), ENCODED PROTEINS AND THEIR APPLICATIONS
ATE444967T1 (en) SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2
YU19903A (en) Novel receptor nucleic acids and polypeptides
ATE500323T1 (en) SUBTILISIN VARIANT
EP1067182A8 (en) Secretory protein or membrane protein
DK1095140T3 (en) Neurotrophic factors
WO2001064834A8 (en) Novel nucleic acids and polypeptides
CY1107628T1 (en) HUMAN CTLA-4 ANTIBODIES AND USES
DE69637844D1 (en) NEW TGF-BETA-SIMILAR CYTOKIN
WO2002014485A3 (en) Kallikrein gene
ATE509103T1 (en) NEUROTROPHIC FACTORS
SE9801455D0 (en) New receptor
DE60139544D1 (en) MODIFIED, FLUORESCENT PROTEINS
ATE321853T1 (en) HUMANIC PELLINO-POLYPEPTIDES
ATE369429T1 (en) STRUCTURAL PROTEINS OF THE VIRUS CAUSING PANCREAS DISEASE IN FISH AND THEIR USES
SE9602822D0 (en) New receptor
WO2001064840A8 (en) Novel bone marrow nucleic acids and polypeptides
DK0939769T3 (en) The vertebrate Smoothened proteins
EA200400392A1 (en) BINDING KASPAZU-8 PROTEIN, ITS OBTAINING AND APPLICATION
DK1005532T3 (en) Isolated nucleic acid molecules encoding SSX family members and their applications
BR0014167A (en) Proteìna iren, its preparation and application
ATE265418T1 (en) NEW SUBSTITUTED 3-PHENOXY AND 3-PHENYLALKYLOXY-2-PHENYL-PROPYLAMINES
ATE412753T1 (en) ANTIBACTERIAL PROTEIN CHLAMYSIN-B, GENE CODING THEREOF AND AN EXPRESSION SYSTEM THEREOF
ITMI20001056A0 (en) CODING POLYNUCLEOTIDES FOR POLYMORPHIC FORMS OF THE PTHRP PROTEIN, THE CODED PROTEINS, AND THEIR THERAPEUTIC APPLICATIONS.
WO2002033058A3 (en) Novel cysteine proteases and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

D17 Declaration under article 17(2)a
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP